Special presentationIschemia and Reperfusion Injury in Liver Transplantation
Section snippets
Cell Cascades
Ample evidence suggests that activation of Kupffer cells, PMN, endothelial cells (EC) and reactive oxygen species (ROS) are all critical in the pathogenesis of I/R injury.1, 2 The final consequence of these interrelated processes are structural tissue alterations causing hepatocellular dysfunction. The histopathologic changes that occur in ischemic liver after reperfusion include cellular swelling, vacuolization, EC disruption, and PMN infiltration. It seems that nonparenchymal cells (Kupffer,
Heme oxygenase system
Heme oxygenases (HO) are ubiquitous enzymes that catalyze the rate-limiting steps in the oxidative degradation of heme into biliverdin, carbon monoxide (CO) and free iron. Biliverdin is reduced to bilirubin by bilirubin reductase, and the free iron used in intracellular metabolism or sequestered in ferritin. It is believed that the byproducts derived from the catalysis of heme by HO, namely biliverdin, bilirubin, and ferritin accumulated from released iron, and finally CO, can all mediate the
Future research
The primary nonspecific injury (such as I/R injury) to the donor organ induces events of the two distinct immunologic defense systems: (1) a more broadly directed innate immune host defense (evolutionary directed normally against infections), resulting in (2) a definite adaptive immune host defense that leads ultimately to a specific graft injury (i.e., rejection). Indeed, I/R injury may create a milieu of inflammation that operates as a “danger” signal in OLTs, and in analogy to the infectious
References (33)
- et al.
Current status of ischemia and reperfusion injury in the liver
Transplant Rev
(2000) - et al.
Hepatic ischemia/reperfusion injury—a fresh look
Exp Mol Pathol
(2003) - et al.
P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury
Am J Transplant
(2002) - et al.
STAT4 and STAT6 signaling in hepatic ischemia/reperfusion injury in miceHO-1 dependence of STAT4 disruption-mediated cytoprotection
Hepatology
(2003) - et al.
FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration
Am J Transplant
(2002) Reactive oxygen and ischemia/reperfusion injury of the liver
Chem Biol Interact
(1991)- et al.
Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion
Hepatology
(2001) - et al.
A novel strategy against ischemia and reperfusion injurycytoprotection with heme oxygenase system
Transpl Immunol
(2002) - et al.
Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation
Hepatology
(1998) - et al.
Principles of solid-organ preservation by cold storage
Transplantation
(1998)
Kupffer cell activation and endothelial cell damage after storage of rat liverseffects of reperfusion
Hepatology
CD18 integrin and CD54-dependent neutrophil adhesion to cytokine-stimulated human hepatocytes
Am J Physiol
The reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1
Ann Surg
Biologically active products of stimulated liver macrophages (Kupffer cells)
Eur J Biochem
Reperfusion injury to endothelial cells following cold ischemic storage of rat livers
Hepatology
Improved graft survival after renal transplantation in the United States, 1988 to 1996
N Engl J Med
Cited by (221)
Camera-based blood oxygen measurement
2021, Contactless Vital Signs MonitoringOmega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling
2019, Journal of Pediatric Surgery4-phenyl butyric acid improves hepatic ischemia/reperfusion and affects gene expression of ABC transporter Abcc5 in rats
2023, Croatian Medical Journal
Supported by NIH Grant DK63560, AI23847, AI42223, and The Dumont Research Foundation.